Reduced cardiorespiratory fitness is a mediator of excess all-cause mortality in rheumatoid arthritis: the Trøndelag Health Study.
arthritis
epidemiology
health care
outcome assessment
rheumatoid
Journal
RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
08
12
2020
revised:
08
02
2021
accepted:
17
02
2021
entrez:
9
3
2021
pubmed:
10
3
2021
medline:
1
9
2021
Statut:
ppublish
Résumé
Investigate if low cardiorespiratory fitness (CRF) was associated with and acted as a mediator of excess all-cause mortality rate in persons suffering from rheumatoid arthritis (RA) compared with the general population. All-cause mortality was analysed using Cox regression modelling in patients with RA (n=348) and controls (n=60 938) who took part in the second (1995-1997) and third (2006-2008) waves of the longitudinal population-based Trøndelag Health Study in Norway. A mediation analysis was performed to investigate if excess relative risk of mortality in RA was mediated by low estimated CRF (eCRF). During the follow-up until 31 December 2018 (mean 19.3 years), the mortality rate among patients with RA (n=127, 36.5%) was higher than among controls (n=12 942, 21.2%) (p<0.001). Among controls and patients with RA, 51% and 26%, respectively, had eCRF above the median for their age and sex (p<0.001). The final Cox model included RA status and eCRF, adjusted for hypertension, body mass index, smoking, cholesterol, diabetes and creatinine. eCRF below median for sex and age category was associated with increased mortality (p<0.001). The total excess relative risk of mortality in patients with RA was 28% (95% CI 2% to 55%, p=0.035), in which RA itself contributed 5% and the direct and indirect contributions of low eCRF accounted for 23%. Low eCRF was an important mediator of the increased all-cause mortality rate found in RA. Our data indicate that patients with RA should be given advice to perform physical activity that increases CRF, along with optimised treatment with antirheumatic drugs, from the time of diagnosis.
Identifiants
pubmed: 33685930
pii: rmdopen-2020-001545
doi: 10.1136/rmdopen-2020-001545
pmc: PMC7942264
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Med Sci Sports Exerc. 2019 Jun;51(6):1270-1281
pubmed: 31095084
BMC Musculoskelet Disord. 2012 Oct 18;13:202
pubmed: 23078261
RMD Open. 2019 Apr 20;5(1):e000912
pubmed: 31168415
Ann Rheum Dis. 2017 Jun;76(6):948-959
pubmed: 27979873
Ann Rheum Dis. 2017 Jun;76(6):1057-1063
pubmed: 28031164
Ann Rheum Dis. 2018 Sep;77(9):1251-1260
pubmed: 29997112
Ann Rheum Dis. 2015 Mar;74(3):480-9
pubmed: 25561362
Sci Rep. 2020 Feb 27;10(1):3593
pubmed: 32108158
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Ann Rheum Dis. 2011 Mar;70(3):508-11
pubmed: 21149499
Ann Rheum Dis. 2012 Sep;71(9):1524-9
pubmed: 22425941
Int J Epidemiol. 2013 Aug;42(4):968-77
pubmed: 22879362
RMD Open. 2020 Jan;6(1):
pubmed: 31958278
Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S14-20
pubmed: 19026141
Ann Rheum Dis. 2017 Jan;76(1):17-28
pubmed: 27697765
Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S35-61
pubmed: 19026144
Ann Rheum Dis. 2018 Jan;77(1):85-91
pubmed: 28970218
Rheumatol Int. 2021 Feb;41(2):369-379
pubmed: 33037488
Eur Heart J. 2013 Mar;34(10):750-8
pubmed: 22555215
Med Sci Sports Exerc. 2014 Jun;46(6):1159-65
pubmed: 24576863
J Rheumatol. 2017 Aug;44(8):1134-1141
pubmed: 28412703
Med Sci Sports Exerc. 2011 Jul;43(7):1334-59
pubmed: 21694556
Ann Intern Med. 1994 Jan 1;120(1):26-34
pubmed: 8250453
Med Sci Sports Exerc. 2011 Sep;43(9):1675-9
pubmed: 21364479
J Am Heart Assoc. 2019 May 7;8(9):e010293
pubmed: 30991880
Ann Rheum Dis. 2011 May;70(5):812-7
pubmed: 21288959
Best Pract Res Clin Rheumatol. 2003 Oct;17(5):753-81
pubmed: 12915156
Arthritis Rheum. 1983 Nov;26(11):1346-53
pubmed: 6639693
Best Pract Res Clin Rheumatol. 2007 Aug;21(4):601-28
pubmed: 17678823
Med Sci Sports Exerc. 2011 Nov;43(11):2024-30
pubmed: 21502897
Arthritis Res Ther. 2010;12(4):R158
pubmed: 20712865
Int J Epidemiol. 2018 Nov 16;:
pubmed: 30452641
Semin Arthritis Rheum. 2019 Apr;48(5):808-814
pubmed: 30205983
Med Sci Sports Exerc. 2016 Apr;48(4):625-32
pubmed: 26587846
Rheumatology (Oxford). 2009 Oct;48(10):1309-13
pubmed: 19696061
Arthritis Care Res (Hoboken). 2018 Dec;70(12):1748-1755
pubmed: 29512334
Br J Sports Med. 2014 Aug;48(16):1227-34
pubmed: 24144531
Med Sci Sports Exerc. 2020 Jun;52(6):1248-1255
pubmed: 31977641
Cells. 2020 Feb 19;9(2):
pubmed: 32092988
Rheumatology (Oxford). 2015 Dec;54(12):2215-20
pubmed: 26209790
Circulation. 2016 Dec 13;134(24):e653-e699
pubmed: 27881567
Atherosclerosis. 2008 Feb;196(2):756-63
pubmed: 17266963
Ann Rheum Dis. 2013 Nov;72(11):1819-25
pubmed: 23155222
Mayo Clin Proc. 2017 Feb;92(2):218-227
pubmed: 27866655
J Autoimmun. 2014 Feb-Mar;48-49:26-30
pubmed: 24568777
Rheumatology (Oxford). 2020 Mar 1;59(3):505-512
pubmed: 31504942